Streetbeat News

Products Services

DPRO

Draganfly's Commander 3XL will be used as the primary transport vehicle for TB2 Aerospace's DROPS UAV Cargo POD, enhancing autonomous tactical resupply capabilities.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:00 am

DPRO

Draganfly has received a military purchase order for its Commander 3XL drone to be used for logistics within various branches of the U.S. Department of Defense.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 11:00 am

HE

LBRDA

QQQ

SNOW

SPY

The article discusses the impact of China's economic stimulus on global markets, with a focus on commodities and US stock futures. It highlights the performance of major indices and ETFs, and mentions specific stocks like Liberty Broadband, Snowflake, and Hawaiian Electric, which experienced significant premarket movements. Analysts provide insights on market trends, emphasizing the importance of differentiating between genuine and speculative AI-driven companies.

Portfolio Pulse from Shanthi Rexaline

September 24, 2024 | 10:58 am

F

Ford has announced that order banks are now open for the 2025 Ford F-Series Super Duty, indicating strong demand and potential revenue growth for the company.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:37 am

AAPL

Marques Brownlee reviewed Apple's iPhone 16, highlighting its unfinished feel due to missing AI features. Despite design and performance improvements, the launch has mixed reactions, with concerns over demand and competition from Huawei.

Portfolio Pulse from Ananya Gairola

September 24, 2024 | 10:33 am

ZUO

Zuora has introduced new AI enhancements at Subscribed Live London, allowing customers to activate an AI paywall for better insights into subscriber behavior, aiming to boost conversion and revenue growth.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:13 am

NVS

Generate:Biomedicines has entered a collaboration with Novartis to develop protein therapeutics, with a potential transaction value exceeding $1 billion. Generate will receive $65 million upfront, including $15 million in equity, and is eligible for milestone payments and royalties.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:12 am

BCLI

BrainStorm Cell Therapeutics is set to present the latest updates on its NurOwn therapy at the upcoming NEALS meeting. This presentation could provide insights into the progress and potential of NurOwn, which is significant for investors tracking the company's developments.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:09 am

CPRX

Catalyst Pharmaceuticals' FIRDAPSE has been approved in Japan for treating Lambert-Eaton Myasthenic Syndrome (LEMS), marking a significant milestone for the company and its sub-licensee, DyDo Pharma. This approval expands FIRDAPSE's reach beyond the U.S., where it is already a leading therapy for LEMS.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:08 am

LLY

Eli Lilly announced that Japan has approved its drug Kisunla (Donanemab-azbt) for early symptomatic Alzheimer's disease. The approval was based on data from the TRAILBLAZER-ALZ 2 Phase 3 clinical study.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 10:07 am